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Portable technology evaluates bone loss
Astronauts lose signiﬁcant bone mass during lengthy space ﬂights. NASA 
wishes to monitor this bone loss in order to develop nutritional and exercise 
countermeasures. Operational Technologies Corporation (OpTech) has devel-
oped a handheld device that quantiﬁes bone loss in a spacecraft environment. 
The innovation works by adding ﬂuorescent dyes and quenchers to aptamers to 
enable pushbutton, one-step bind-and-detect FRET assays that can be freeze-
dried, rehydrated with body ﬂuids, and used to quantify bone loss.
In Phase I, OpTech developed several 15-minute speciﬁc polyclonal  
FRET-aptamer assays with low nanogram/milliliter sensitivity. The company 
also cloned and sequenced 110 bone marker and calcidiol aptamers. During 
Phase II, OpTech freeze-dried and packaged optimized FRET-aptamer assays 
for use with a plastic cuvette and body ﬂuid collection system. The assay system 
is coupled with a handheld, battery-operated ﬂuorometer customized to detect 
bone markers and calcidiol in urine and serum. Sensitive and accurate  
(low ng/mL detection with correlation coeﬃcients >0.95), the innovation 
produces results in 15–30 minutes.
Black Hole Quencher is a registered trademark of Biosearch Technologies, Inc.
Applications
NASA 
 ` Astronaut self-monitoring 
of bone loss and bone loss 
treatments (e.g., vitamin D 
augmentation)
 ` Monitoring other clinical 
analytes (e.g., glucose, environ-
mental microbes in water) with 
development of appropriate 
FRET assays
Commercial
 ` Rapid point-of-care diagnostic 
system for osteoporosis and its 
treatment
 ` Monitoring system for bone 
repair following severe fractures 
and skeletal procedures
Phase II Objectives
 ` Synthesize red-region Black Hole 
Quencher® deoxyribonucleotide 
triphosphates (dNTPs)
 ` Screen all 110 Phase I aptamer 
sequences for best FRET with 
bone peptides, hydroxylysine, and 
25-hydroxyvitamin D
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 ` Complete three-dimensional modeling 
of selected aptamer targets
 ` Freeze-dry and retest FRET assays in 
serum and urine samples
 ` Coordinate optics and firmware 
changes for operation in red fluores-
cence window of serum and urine
 ` Develop software package
 ` Develop and produce plastic cuvette 
and body fluid sampling syringe system
 ` Integrate system components, 
including assays, handheld sensor, and 
laptop computer
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 ` Rapid (15–30 minutes)
 ` Easy to use aboard a spacecraft, in 
a physician’s office, or at home with 
freeze-dried assay reagents
 ` Compact (handheld fluorometer)
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